Theravance Biopharma buy melinda
Start price
03.08.17
/
50%
€28.90
Target price
26.12.17
€37.88
Performance (%)
-13.61%
End price
26.12.17
€24.97
Summary
This prediction ended on 26.12.17 with a price of €24.97. The price of Theravance Biopharma has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.61%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Theravance Biopharma | -3.614% | -3.614% | 73.913% | 65.803% |
| iShares Core DAX® | 0,39 % | 0,15 % | 10,96 % | 58,44 % |
| iShares Nasdaq 100 | 1,31 % | -2,55 % | -0,61 % | 84,24 % |
| iShares Nikkei 225® | -0,46 % | 6,89 % | 26,75 % | 63,40 % |
| iShares S&P 500 | 1,31 % | -1,16 % | -0,04 % | 58,22 % |
Comments by melinda for this prediction
In the thread Theravance Biopharma diskutieren
Gesundheit | Biotechnologie | Cayman Islands
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Theravance Biopharma
Theravance Biopharma
Start price
Target price
Perf. (%)
€22.20
11.03.20
11.03.20
€25.00
21.08.20
21.08.20
-29.73%
21.08.20
21.08.20
Theravance Biopharma
Start price
Target price
Perf. (%)
€25.38
10.02.18
10.02.18
€32.11
13.08.18
13.08.18
-0.43%
13.08.18
13.08.18
Theravance Biopharma
Start price
Target price
Perf. (%)
€32.04
03.08.17
03.08.17
€42.00
26.12.17
26.12.17
-13.61%
26.12.17
26.12.17